Edie Mulry, Australia's first child diagnosed with JELANS, a rare genetic condition, has sparked hope for families facing similar challenges. JELANS, or Jeffries-Lakhani Neurodevelopmental Syndrome, is an extremely rare disorder causing developmental delays and life-threatening seizures. With only two known cases in Australia and about 30 worldwide, the condition lacks established treatments and funding for research. The Mulry family, along with the small global community of 'CRELD1 Warriors', are taking action. They are raising funds to support research and progress for all children living with CRELD1-related disorders. The funds will be used for a crucial 'drug repurposing' study, where researchers will create living cell models from skin biopsies of children with the mutation to identify potential medications that could restore normal behavior. This innovative approach offers a glimmer of hope for children like Edie, who suffer from daily seizures and developmental delays. But here's where it gets controversial: the lack of established treatments and funding for research is a significant barrier to progress. The Mulrys' story highlights the importance of community action and the need for increased awareness and support for rare genetic conditions. As the family continues their fight, they invite readers to join them in supporting this critical research and making a difference in the lives of children like Edie.